News from Anthera Pharmaceuticals, Inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

30 Jan, 2014, 16:42 ET Anthera Pharmaceuticals to Present at Leerink Swann, Cowen & Co., and BIO CEO Healthcare Conferences

 Anthera Pharmaceuticals, Inc. (NASDAQ:ANTH), a biopharmaceutical company focused on developing and commercializing products to treat...


27 Nov, 2013, 17:00 ET Anthera Pharmaceuticals to Present at Annual Piper Jaffray Healthcare Conference

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company focused on developing and commercializing products to treat autoimmune...


29 Oct, 2013, 16:30 ET Anthera Pharmaceuticals Reports 2013 Third Quarter Financial Results, Clinical and Regulatory Update

 Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH), today announced financial results, clinical and regulatory update for the quarter ended...


25 Sep, 2013, 08:30 ET Anthera Pharmaceuticals Announces Emerging Data from Phase 2 Open-Label Extension Study to be Presented at the ACR/ARHP 2013 Annual Scientific Meeting

Anthera Pharmaceuticals (NASDAQ: ANTH), a biopharmaceutical company focused on developing and commercializing products to treat autoimmune...


30 Jul, 2013, 17:14 ET Anthera Pharmaceuticals Reports 2013 Second Quarter Financial Results

Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH), today announced financial results and business highlights for the quarter ended June 30, 2013....


12 Jul, 2013, 17:00 ET Anthera Pharmaceuticals Announces 1-for-8 Reverse Split of Stock

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH) announced today that it has filed a Certificate of Amendment to its Amended and Restated Certificate...


24 Jun, 2013, 08:30 ET Anthera Announces Initiation of BRIGHT-SC Phase 2 Clinical Study in IgA Nephropathy with Blisibimod

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with autoimmune...


21 Jun, 2013, 16:45 ET Anthera Pharmaceuticals Announces Receipt of Nasdaq Notice

 Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH) (the "Company"), a biopharmaceutical company focused on developing and commercializing products...


12 Jun, 2013, 16:30 ET Anthera Pharmaceuticals Announces Personnel Changes

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH) today announced the appointment of May Liu as its Senior Vice President, Finance and...


31 May, 2013, 15:00 ET Anthera Pharmaceuticals to Present at Annual Jefferies Healthcare Conference

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company focused on developing and commercializing products to treat autoimmune...


13 May, 2013, 17:23 ET Anthera Pharmaceuticals Reports 2013 First Quarter Financial Results

 Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH), today announced financial results and business highlights for the quarter ended March 31st,...


07 May, 2013, 16:30 ET Anthera Pharmaceuticals Announces Additional Data from Phase 2b PEARL-SC Blisibimod Study

 Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company focused on developing and commercializing products to treat...


03 May, 2013, 14:06 ET Anthera Announces First Quarter 2013 Financial Report and Conference Call

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company focused on developing and commercializing products to treat autoimmune...


05 Apr, 2013, 17:45 ET Anthera Refinances Existing Debt with New $20 Million Credit Facility and Secures $18.5 Million Committed Equity Financing Facility

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation,...


27 Mar, 2013, 16:15 ET Anthera Initiates CHABLIS-SC1 Phase 3 Clinical Study in Lupus with Blisibimod

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation...


26 Mar, 2013, 16:15 ET Anthera Pharmaceuticals Reports 2012 Fourth Quarter And Fiscal Year Financial Results

 Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH), today announced financial results and business highlights for the quarter and fiscal year ended...


22 Mar, 2013, 08:00 ET Anthera Announces Data from the Phase 2b PEARL-SC Study Will Be Presented at the 10th International Congress on Systemic Lupus Erythematosus

 Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with...


07 Feb, 2013, 17:29 ET Anthera Pharmaceuticals to Present at the 2013 Leerink Global Healthcare Conference

 Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH) a biopharmaceutical company developing drugs to treat serious diseases associated with...


05 Feb, 2013, 08:30 ET Anthera Pharmaceuticals Announces Departure of Georgina Kilfoil

 Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH) today announced that Senior Vice President of Product Development Georgina Kilfoil has...


30 Jan, 2013, 09:48 ET Anthera Pharmaceuticals Announces Completion of Public Offering of Common Stock

 Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH) today announced that it has completed the previously announced underwritten public offering...